Angiotropic Lymphoma: An Immunophenotypically and Clinically Heterogeneous Lymphoma

[1]  R. Tubbs,et al.  Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. , 2000, The American journal of surgical pathology.

[2]  G. Arrigoni,et al.  Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. , 2000, Human pathology.

[3]  Y. Kwong,et al.  Epstein-Barr virus-related intravascular lymphomatosis. , 2000, The American journal of surgical pathology.

[4]  原田 信助.  Molecular and immunological dissection of diffuse large B cell lymphoma : CD5[+], and CD5[-] with CD10[+] groups may constitute clinically relevant subtypes , 2000 .

[5]  S. Alkan,et al.  Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. , 2000, The American journal of surgical pathology.

[6]  K. Ohshima,et al.  Prognostic clinicopathologic factors, including immunologic expression in diffuse large B‐cell lymphomas , 1999, Pathology international.

[7]  G Flandrin,et al.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  R. Prayson,et al.  Angiotrophic large cell lymphoma mimicking multiple sclerosis associated transverse myelitis , 1999, Journal of Clinical Neuroscience.

[10]  M. Seto,et al.  Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5− with CD10+ groups may constitute clinically relevant subtypes , 1999, Leukemia.

[11]  L. Medeiros,et al.  Intravascular large B-cell lymphoma: A report of five cases initially diagnosed by bone marrow biopsy , 1999 .

[12]  P. Ward,et al.  Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas. , 1999, Leukemia & lymphoma.

[13]  R. Gascoyne,et al.  Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. , 1999, Human pathology.

[14]  S. Alkan,et al.  Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders. , 1999, American journal of clinical pathology.

[15]  H. Shiku,et al.  De novo CD5‐positive diffuse large B‐cell lymphoma: clinical characteristics and therapeutic outcome , 1999, British journal of haematology.

[16]  J. Jouet,et al.  SUCCESSFUL AUTOLOGOUS BONE MARROW TRANSPLANTATION IN INTRAVASCULAR LYMPHOMATOSIS , 1999, British journal of haematology.

[17]  C. Hsiao,et al.  Epstein-Barr virus-associated intravascular lymphomatosis within Kaposi's sarcoma in an AIDS patient. , 1999, The American journal of surgical pathology.

[18]  K. Ohshima,et al.  Intravascular large cell lymphoma: clinicopathological, immuno-histochemical and molecular genetic studies. , 1999, Leukemia & lymphoma.

[19]  E. Shuster,et al.  Intravascular lymphomatosis. A report of ten patients with central nervous system involvement and a review of the disease process. , 1999, Advances in experimental medicine and biology.

[20]  K. Ohshima,et al.  Intravascular large cell lymphoma associated with hypoalbuminemia. , 1998, Leukemia & lymphoma.

[21]  L. Medeiros,et al.  Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[22]  D. Arber,et al.  Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[23]  J. Zic,et al.  Intravascular large cell lymphoma: a patient with asymptomatic purpuric patches and a chronic clinical course. , 1998, Journal of the American Academy of Dermatology.

[24]  T. Yoshino,et al.  bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[25]  I. Lossos,et al.  Intravascular lymphomatosis--an indolent or aggressive entity? , 1998, Leukemia & lymphoma.

[26]  T. Suchi,et al.  Malignant histiocytosis‐like B‐cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature , 1997, British journal of haematology.

[27]  W. Au,et al.  T‐cell intravascular lymphomatosis (angiotropic large cell lymphoma): association with Epstein–Barr viral infection , 1997, Histopathology.

[28]  H. Kerl,et al.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. , 1997, Blood.

[29]  J C Reed,et al.  Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.

[30]  J. Snowden,et al.  Angiotropic lymphoma: report of a case with histiocytic features. , 1997, Journal of clinical pathology.

[31]  K. Batts,et al.  Angiotropic large cell lymphoma (intravascular lymphomatosis) occurring after follicular small cleaved cell lymphoma. , 1996, Mayo Clinic proceedings.

[32]  D. Jong,et al.  T‐cell rich B‐cell non‐Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease , 1996, Histopathology.

[33]  S. Pittaluga,et al.  BCL‐6 EXPRESSION IN REACTIVE LYMPHOID TISSUE AND IN B‐CELL NON‐HODGKIN'S LYMPHOMAS , 1996, The Journal of pathology.

[34]  S. Blasius,et al.  Primary non-Hodgkin lymphomas of the CNS-proliferation, oncoproteins and Epstein-Barr-virus. , 1996, General & diagnostic pathology.

[35]  R. Prayson.  Angiotropic Large Cell Lymphoma: Simultaneous peripheral nerve and skeletal muscle involvement , 1996, Pathology.

[36]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[37]  S. Mori,et al.  BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. , 1995, Blood.

[38]  Joseph A. DiGiuseppe,et al.  Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  R. Braylan,et al.  Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type. , 1994, Human pathology.

[40]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[41]  J. Sloane,et al.  Intravascular malignant lymphomatosis (angiotropic large‐cell lymphoma). A case report with evidence for T‐cell lineage with polymerase chain reaction analysis , 1994, Histopathology.

[42]  H. Shahidullah,et al.  Intravascular histiocytosis , 1994, Histopathology.

[43]  Douglas C. Miller,et al.  Intravascular lymphomatosis a systemic disease with neurologic manifestations , 1993, Cancer.

[44]  M. Setoyama,et al.  A Case of Intravascular Malignant Lymphomatosis (Angiotropic Large‐cell Lymphoma) Presenting Memory T Cell Phenotype and Its Expression of Adhesion Molecules , 1992, The Journal of dermatology.

[45]  P. Umbert,et al.  Malignant proliferative angioendotheliomatosis or angiotropic lymphoma associated with a soft-tissue lymphoma. , 1992, Journal of the American Academy of Dermatology.

[46]  M. Stoler,et al.  Angiotropic large-cell lymphoma in a patient with adrenal insufficiency. , 1991, Archives of pathology & laboratory medicine.

[47]  S. Mills,et al.  Intravascular lymphomatosis: clinicopathologic features and differential diagnosis. , 1991, Seminars in diagnostic pathology.

[48]  T. Tada,et al.  Congenital angiotropic lymphoma (intravascular lymphomatosis) of the T‐cell type , 1991, Cancer.

[49]  H. Battifora,et al.  Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations , 1990, Cancer.

[50]  C. Bartram,et al.  "Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. , 1990, Human pathology.

[51]  I. Katayama,et al.  Primary hepatic lymphoma presenting as intravascular lymphomatosis. , 1990, Archives of Pathology & Laboratory Medicine.

[52]  M. G. Fleming,et al.  Malignant angioendotheliomatosis: an angiotropic lymphoma. , 1989, Journal of the American Academy of Dermatology.

[53]  P. Hall,et al.  Angiotropic large cell lymphoma (ALCL): Morphological, immunohistochemical and genotypic studies with analysis of previous reports , 1989, Hematological oncology.

[54]  N. Harris,et al.  Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors. , 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[55]  J. Ben-Ezra,et al.  Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma. , 1986, The New England journal of medicine.

[56]  B. Scheithauer,et al.  Reassessment of Malignant “Angioendotheliomatosis”: Evidence in Favor of Its Reclassification as “Intravascular Lymphomatosis” , 1986, The American journal of surgical pathology.

[57]  S. Mills,et al.  Malignant angioendotheliomatosis. An angiotropic lymphoma? , 1985, American journal of clinical pathology.

[58]  S. Wolff,et al.  Malignant lymphoma and malignant angioendotheliomatosis: One disease , 1985, Cancer.

[59]  S. Cohen,et al.  Histiocytic lymphoma and malignant angioendotheliomatosis. One disease or two? , 1982, Cancer.

[60]  P. Scott,et al.  Proliferating angioendotheliomatosis. , 1975, Archives of pathology.

[61]  J. N. Harris-Jones,et al.  Intravascular endothelioma (endothelioma in situ, systemic endotheliomatosis) , 1964, Journal of clinical pathology.

[62]  I. Braverman,et al.  Diffuse Malignant Proliferation of Vascular Endothelium: A Possible New Clinical and Pathological Entity , 1961 .

[63]  J. Tappeiner,et al.  [On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis?]. , 1959, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.